Literature DB >> 11089974

Regulation of repulsion versus adhesion by different splice forms of an Eph receptor.

J Holmberg1, D L Clarke, J Frisén.   

Abstract

Eph tyrosine kinase receptors and their membrane-bound ephrin ligands mediate cell interactions and participate in several developmental processes. Ligand binding to an Eph receptor results in tyrosine phosphorylation of the kinase domain, and repulsion of axonal growth cones and migrating cells. Here we report that a subpopulation of ephrin-A5 null mice display neural tube defects resembling anencephaly in man. This is caused by the failure of the neural folds to fuse in the dorsal midline, suggesting that ephrin-A5, in addition to its involvement in cell repulsion, can participate in cell adhesion. During neurulation, ephrin-A5 is co-expressed with its cognate receptor EphA7 in cells at the edges of the dorsal neural folds. Three different EphA7 splice variants, a full-length form and two truncated versions lacking kinase domains, are expressed in the neural folds. Co-expression of an endogenously expressed truncated form of EphA7 suppresses tyrosine phosphorylation of the full-length EphA7 receptor and shifts the cellular response from repulsion to adhesion in vitro. We conclude that alternative usage of different splice forms of a tyrosine kinase receptor can mediate cellular adhesion or repulsion during embryonic development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11089974     DOI: 10.1038/35041577

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  109 in total

1.  Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.

Authors:  S Elowe; S J Holland; S Kulkarni; T Pawson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  EphB6 crosslinking results in costimulation of T cells.

Authors:  Hongyu Luo; Guang Yu; Yulian Wu; Jiangping Wu
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

3.  Mistargeting hippocampal axons by expression of a truncated Eph receptor.

Authors:  Yong Yue; Zhi-Yong Chen; Nick W Gale; Jan Blair-Flynn; Tian-Jing Hu; Xin Yue; Margaret Cooper; David P Crockett; George D Yancopoulos; Lino Tessarollo; Renping Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-17       Impact factor: 11.205

4.  Loss-of-function analysis of EphA receptors in retinotectal mapping.

Authors:  David A Feldheim; Masaru Nakamoto; Miriam Osterfield; Nicholas W Gale; Thomas M DeChiara; Rajat Rohatgi; George D Yancopoulos; John G Flanagan
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

Review 5.  Molecular mechanisms of cell segregation and boundary formation in development and tumorigenesis.

Authors:  Eduard Batlle; David G Wilkinson
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

6.  EphA signaling impacts development of topographic connectivity in auditory corticofugal systems.

Authors:  Masaaki Torii; Troy A Hackett; Pasko Rakic; Pat Levitt; Daniel B Polley
Journal:  Cereb Cortex       Date:  2012-04-05       Impact factor: 5.357

Review 7.  Eph/ephrin molecules--a hub for signaling and endocytosis.

Authors:  Mara E Pitulescu; Ralf H Adams
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

Review 8.  Mechanisms of ephrin-Eph signalling in development, physiology and disease.

Authors:  Artur Kania; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-21       Impact factor: 94.444

Review 9.  Current perspectives on the genetic causes of neural tube defects.

Authors:  Patrizia De Marco; Elisa Merello; Samantha Mascelli; Valeria Capra
Journal:  Neurogenetics       Date:  2006-08-29       Impact factor: 2.660

10.  EphB6-null mutation results in compromised T cell function.

Authors:  Hongyu Luo; Guang Yu; Johanne Tremblay; Jiangping Wu
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.